First Trust Nasdaq Pharmaceuticals ETF
FTXH
6 hedge funds and large institutions have $958K invested in First Trust Nasdaq Pharmaceuticals ETF in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.
61% more capital invested
Capital invested by funds: $594K → $958K (+$364K)
14.8% more ownership
Funds ownership: 10.15% → 24.95% (+15%)
25% less funds holding
Funds holding: 8 → 6 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$803K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$10.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$248K |
| 2 |
MWPCG
Measured Wealth Private Client Group
Portsmouth,
New Hampshire
|
-$47K |
| 3 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$12K |
| 4 |
APA
American Portfolios Advisors
Holbrook,
New York
|
-$5.87K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $717K | +$803K | +37,345 | New |
|
|
SMFS
2
Squar Milner Financial Services
Irvine,
California
| $108K | – | – | – |
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $68K | – | – | – |
|
|
4
Bank of America
Charlotte,
North Carolina
| $50K | +$10.7K | +500 | +24% |
|
|
LTFS
5
Ladenburg Thalmann Financial Services
Miami,
Florida
| $13K | – | – | – |
|
|
CA
6
Claro Advisors
Boston,
Massachusetts
| $2K | +$1.81K | +84 | New |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$248K | -10,650 | Closed |
|
|
MWPCG
8
Measured Wealth Private Client Group
Portsmouth,
New Hampshire
| – | -$47K | -2,000 | Closed |
|
|
SWP
9
Stratos Wealth Partners
Beachwood,
Ohio
| – | -$12K | -501 | Closed |
|
|
APA
10
American Portfolios Advisors
Holbrook,
New York
| – | -$5.87K | -250 | Closed |
|
FTXH Hedge Fund Activity: Q4 2018 in Review
6 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) for Q4 2018, worth a combined $958K — up 61% from $594K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of FTXH and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, opening a new position worth an estimated $803K. The largest seller was Citadel Advisors, exiting entirely with an estimated $248K sold.
- 6 institutional investors held First Trust Nasdaq Pharmaceuticals ETF (FTXH) as of Q4 2018, down from 8 in Q3 2018.
- Funds reported $958K of First Trust Nasdaq Pharmaceuticals ETF stock for Q4 2018, up 61% quarter-over-quarter.
- 2 funds opened new First Trust Nasdaq Pharmaceuticals ETF positions in Q4 2018 and 4 closed out, a net change of -2 holders.
- The largest First Trust Nasdaq Pharmaceuticals ETF buyer in Q4 2018 was Jane Street, an estimated $803K added.
- The largest First Trust Nasdaq Pharmaceuticals ETF seller in Q4 2018 was Citadel Advisors, an estimated $248K sold.
Based on aggregated 13F filings for Q4 2018.